Evidence map›Paper›PMID 23341464›Full record

ArticleThe Journal of biological chemistry2013

Streptococcus pneumoniae endopeptidase O (PepO) is a multifunctional plasminogen- and fibronectin-binding protein, facilitating evasion of innate immunity and invasion of host cells.

Vaibhav Agarwal, Arunakar Kuchipudi, Marcus Fulde, Kristian Riesbeck, Simone Bergmann, Anna M Blom

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 69 papers.

0numbers the graph read from it
0cells of the map it votes in
69citing papers in PubMed
6.5field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

69 citing papers in PubMed, 103 citations in OpenAlex.

  1. Trial
  2. Article
  3. The truncated major pilin subunit SBP2' contributes toApplied and environmental microbiology · 2026
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Group aMicrobiology spectrum · 2025
    Article
  9. Article
  10. Endopeptidase O promotesVirulence · 2023
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. SPD_0090 Negatively Contributes to Virulence ofFrontiers in microbiology · 2022
    Article
  18. Article
  19. Frontiers in cellular and infection microbiology · 2022
    Review
  20. Review

9 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 2 countries.

Vaibhav AgarwalDepartment of Laboratory Medicine, Medical Protein Chemistry, Lund University, Malmö S-205 02, Sweden.
Arunakar Kuchipudi
Marcus Fulde
Kristian Riesbeck
Simone Bergmann
Anna M Blom
Lund University · SEMedizinische Hochschule Hannover · DETechnische Universität Braunschweig · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Streptococcus pneumoniae infections remain a major cause of morbidity and mortality worldwide. Therefore a detailed understanding and characterization of the mechanism of host cell colonization and dissemination is critical to gain control over this versatile pathogen. Here we identified a novel 72-kDa pneumococcal protein endopeptidase O (PepO), as a plasminogen- and fibronectin-binding protein. Using a collection of clinical isolates, representing different serotypes, we found PepO to be ubiquitously present both at the gene and protein level. In addition, PepO protein was secreted in a growth phase-dependent manner to the culture supernatants of the pneumococcal isolates. Recombinant PepO bound human plasminogen and fibronectin in a dose-dependent manner and plasminogen did not compete with fibronectin for binding PepO. PepO bound plasminogen via lysine residues and the interaction was influenced by ionic strength. Moreover, upon activation of PepO-bound plasminogen by urokinase-type plasminogen activator, generated plasmin cleaved complement protein C3b thus assisting in complement control. Furthermore, direct binding assays demonstrated the interaction of PepO with epithelial and endothelial cells that in turn blocked pneumococcal adherence. Moreover, a pepO-mutant strain showed impaired adherence to and invasion of host cells compared with their isogenic wild-type strains. Taken together, the results demonstrated that PepO is a ubiquitously expressed plasminogen- and fibronectin-binding protein, which plays role in pneumococcal invasion of host cells and aids in immune evasion.

Indexed as

Bacterial AdhesionBacterial ProteinsBlotting, WesternCell Line, TumorCells, CulturedComplement C3bEndopeptidasesEpithelial CellsFibrinolysinFibronectinsHumansHuman Umbilical Vein Endothelial CellsImmune EvasionImmunity, InnateMicroscopy, ConfocalMutationBacterial ProteinsComplement C3bEndopeptidasesFibrinolysinFibronectinsPepO protein, Streptococcus pneumoniaePlasminogenUrokinase-Type Plasminogen Activator

Identifiers

PMID23341464
PMCPMC3591595
OpenAlexW1986606610

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.